American Airlines (AAL) Stock to Fly in 2025 Despite Wall St Turbulence
Wall Street’s reaction to American Airlines’ Q4 earnings numbers was reactionary at best, briefly halting the airline’s long ...
Alto Neuroscience, Inc. (NYSE:ANRO) Receives $20.00 Consensus Price Target from Analysts
Shares of Alto Neuroscience, Inc. (NYSE:ANRO – Get Free Report) have earned an average rating of “Moderate Buy” from the ...
Alto Neuroscience announces $75 million ATM offering
Alto Neuroscience , Inc. (NYSE:ANRO), a pharmaceutical company currently trading at $4.18 per share, has entered into a Sales Agreement with Leerink Partners LLC, initiating an "at the market" ...
Alto Neuroscience files $300M mixed securities shelf
EST Alto Neuroscience (ANRO) files $300M mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
Investing In CyberArk Software: Reasons To Keep It On Your Radar
Is CyberArk overvalued despite recent growth from Venafi acquisition? Find out why it's rated as a Hold in this financial ...
BMO raises Adtalem stock price target to $115, maintains Outperform
BMO Capital Markets expressed a positive outlook on Adtalem Global Education (NYSE:ATGE), as analyst Jeffrey Silber increased the company's price target from $108.00 to $115.00. The firm sustained its ...
Top analyst reworks Palantir stock price target ahead of Q4 earnings
Analysts expect Palantir to post December-quarter earnings of 11 cents a share, up from 8 cents in the year-earlier period, ...